Encompass Health/$EHC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Encompass Health
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- Ticker
- $EHC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 29,699
- Headquarters
- Birmingham, United States
- Website
- www.encompasshealth.com
Encompass Health Metrics
BasicAdvanced
$13B
20.83
$6.13
0.60
$0.78
0.66%
Price and volume
Market cap
$13B
Beta
0.6
52-week high
$129.96
52-week low
$92.77
Average daily volume
891K
Dividend rate
$0.78
Financial strength
Current ratio
1.192
Quick ratio
0.91
Long term debt to equity
0.803
Total debt to equity
0.821
Dividend payout ratio (TTM)
12.11%
Interest coverage (TTM)
8.89%
Profitability
EBITDA (TTM)
1,463.5
Gross margin (TTM)
43.86%
Net profit margin (TTM)
10.01%
Operating margin (TTM)
18.00%
Effective tax rate (TTM)
20.46%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
9.80%
Return on equity (TTM)
24.97%
Valuation
Price to earnings (TTM)
20.832
Price to revenue (TTM)
2.053
Price to book
4.86
Price to tangible book (TTM)
13.05
Price to free cash flow (TTM)
30.814
Free cash flow yield (TTM)
3.25%
Free cash flow per share (TTM)
4.146
Dividend yield (TTM)
0.61%
Forward dividend yield
0.66%
Growth
Revenue change (TTM)
9.47%
Earnings per share change (TTM)
20.15%
3-year revenue growth (CAGR)
10.70%
10-year revenue growth (CAGR)
6.10%
3-year earnings per share growth (CAGR)
25.32%
10-year earnings per share growth (CAGR)
10.42%
3-year dividend per share growth (CAGR)
8.20%
10-year dividend per share growth (CAGR)
-1.89%
What the Analysts think about Encompass Health
Analyst ratings (Buy, Hold, Sell) for Encompass Health stock.
Analyst projections of the future price of Encompass Health stock.
Bulls say / Bears say
Second-quarter revenue rose 9.6%, adjusted EBITDA increased 9.2% and adjusted EPS grew 10.7% year on year. Management raised its 2026 revenue, EBITDA and EPS guidance, indicating that recent operating momentum is carrying into the outlook. (PR Newswire)
Encompass Health is adding capacity where demand is strongest: it opened three hospitals and added 54 beds in the first half, while planning five more hospitals and at least 100 additional beds by year end. Occupancy rose to 77.4%, with 60 hospitals above 90% occupancy, supporting further growth from new and expanded sites. (PR Newswire, The Motley Fool)
North Carolina's repeal of its certificate-of-need rule for inpatient rehabilitation creates a new expansion avenue in an underserved, growing market. Encompass has prioritised 15 markets and has three property parcels under contract, while its first small-format hospital should provide another way to reach smaller communities. (The Motley Fool, PR Newswire)
Medicare Advantage pre-authorisation denials remain a substantial problem, despite some improvement from late 2025 and early 2026. Denials can delay admissions or prevent appropriate patients from reaching Encompass's higher-margin inpatient rehabilitation facilities. (The Motley Fool)
The easy labour savings may be fading: contract labour has fallen sharply, but management said it has reached a point of diminishing returns. Salary, wage and benefit costs are now expected to rise 3.5% to 4% in 2026, which could limit further margin expansion. (The Motley Fool, MarketBeat)
Expansion requires substantial investment before new sites mature: second-quarter adjusted free cash flow fell 4.8% year on year, while pre-opening and ramp-up costs reached $6.9 million. A slower occupancy or staffing ramp at the planned hospitals could weaken cash returns and leave earnings more exposed to execution risk. (PR Newswire, MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 29 Sept 2026.
Encompass Health Financial Performance
Revenues and expenses
Encompass Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Encompass Health News
AllArticlesVideos
Funds containing Encompass Health
AllUSDEURGBP
Fund name | Fund size | $EHC weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.60% |
iShares Ageing Population€AGED | €822M | 0.60% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.37% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.37% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.31% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.